相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-apoptotic Bcl-2 family member Mcl-1 regulates cell viability and bone-resorbing activity of osteoclasts
Hironari Masuda et al.
BONE (2014)
Mechanistic study of the proangiogenic effect of osteoprotegerin
Zahia Benslimane-Ahmim et al.
ANGIOGENESIS (2013)
Osteoprotegerin: Multiple partners for multiple functions
Marc Baud'huin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Denis Lane et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)
Ya-Hui Chiu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Anticancer Efficacy of Apo2L/TRAIL Is Retained in the Presence of High and Biologically Active Concentrations of Osteoprotegerin In Vivo
Irene Zinonos et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets
Maria-Eugenia Chollet et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis
Youngkyun Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Osteoclast-osteoblast communication
Koichi Matsuo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
M. Baud'huin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation
Seoung-Hoon Lee et al.
NATURE MEDICINE (2006)
Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases
Michiyo Kobayashi-Sakamoto et al.
FEMS MICROBIOLOGY LETTERS (2006)
DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
M Yagi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
OSCAR is an FcRγ-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells
E Merck et al.
BLOOD (2004)
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling
S Theoleyre et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival
LB Pritzker et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells
T Standal et al.
BLOOD (2002)
Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro
N Chikatsu et al.
ENDOCRINE JOURNAL (2002)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Bifurcation of osteoclasts and dendritic cells from common progenitors
T Miyamoto et al.
BLOOD (2001)
Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor
A Truneh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells
UM Malyankar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
